Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000899140-20-000174
Filing Date
2020-02-14
Accepted
2020-02-14 16:59:08
Documents
1
Group Members
CUBIST SYSTEMATIC STRATEGIES, LLCPOINT72 CAPITAL ADVISORS, INC.STEVEN A. COHEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A, AMENDMENT #1 pt72_cytokinetics13ga1.htm SC 13G/A 56960
  Complete submission text file 0000899140-20-000174.txt   58533
Mailing Address 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 280 EAST GRAND AVENUE . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Subject) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79858 | Film No.: 20621519
SIC: 2834 Pharmaceutical Preparations

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

EIN.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A